Guidance to develop individual dose recommendations for patients on chronic hemodialysis-Reference-Cited by-同舟云学术

Guidance to develop individual dose recommendations for patients on chronic hemodialysis

Published:2017-05-22 Issue:7 Volume:10 Page:737-752
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Gotta Verena¹,Dao Kim²^ORCID,Rodieux Frédérique¹³,Buclin Thierry²,Livio Françoise²,Pfister Marc¹

Affiliation:

1. Pediatric pharmacology and pharmacometrics, University of Basel Children’s Hospital, UKBB, Basel, Switzerland

2. Division of Clinical Pharmacology, Biomedicine, Department of Laboratories, CHUV, Lausanne, Switzerland

3. Division of Clinical Pharmacology and Toxicology, University Hospitals of Geneva, Geneva, Switzerland

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2017.1323632

Reference68 articles.

1. ERA-EDTA Registry. ERA-EDTA Registry Annual Report 2014. Amsterdam, the Netherlands: Academic Medical Center, Department of Medical Informatics; 2016.

2. Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider

3. Factors associated with medication-related problems in ambulatory hemodialysis patients

4. Systematic comparison of four sources of drug information regarding adjustment of dose for renal function

5. Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources?

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Treatment for Gynecological Cancer Patients Undergoing Hemodialysis;OncoTargets and Therapy;2023-07

2. Update on drug-resistant pulmonary tuberculosis treatment in hemodialysis patients;Indian Journal of Tuberculosis;2023-04

3. Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations;Clinical Lymphoma Myeloma and Leukemia;2022-11

4. Pharmacokinetics in patients requiring renal replacement therapy;Atkinson's Principles of Clinical Pharmacology;2022

5. Creation of an inventory of quality markers used to evaluate pharmacokinetic literature: A systematic review;Journal of Clinical Pharmacy and Therapeutics;2021-10-20